Related references
Note: Only part of the references are listed.Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis
Moonhee Lee et al.
NEUROBIOLOGY OF AGING (2015)
Poly (ADP-ribose) in the pathogenesis of Parkinson's disease
Yunjong Lee et al.
BMB REPORTS (2014)
Poly(ADP-ribose)-mediated interplay of XPA and PARP1 leads to reciprocal regulation of protein function
Jan M. F. Fischer et al.
FEBS JOURNAL (2014)
Discovery of a benzofuran derivative (MBPTA) as a novel ROCK inhibitor that protects against MPP+-induced oxidative stress and cell death in SH-SY5Y cells
Cheong-Meng Chong et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis
Ashley E. Frakes et al.
NEURON (2014)
The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands
Adam J. Pawson et al.
NUCLEIC ACIDS RESEARCH (2014)
Astrocytes protect against diazinon- and diazoxon-induced inhibition of neurite outgrowth by regulating neuronal glutathione
Daniella M. Pizzurro et al.
TOXICOLOGY (2014)
Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP+
A. K. Krug et al.
CELL DEATH & DISEASE (2014)
Evaluation of a human neurite growth assay as specific screen for developmental neurotoxicants
Anne K. Krug et al.
ARCHIVES OF TOXICOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: TRANSPORTERS
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
THE CONCISE GUIDE TO PHARMACOLOGY 2013/14: ENZYMES
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Human iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced Aging
Justine D. Miller et al.
CELL STEM CELL (2013)
Axon degeneration in Parkinson's disease
Robert E. Burke et al.
EXPERIMENTAL NEUROLOGY (2013)
ATF4 Protects Against Neuronal Death in Cellular Parkinson's Disease Models by Maintaining Levels of Parkin
Xiaotian Sun et al.
JOURNAL OF NEUROSCIENCE (2013)
Parthanatos mediates AIMP2-activated age-dependent dopaminergic neuronal loss
Yunjong Lee et al.
NATURE NEUROSCIENCE (2013)
Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells
Yingsha Zhang et al.
NEURON (2013)
Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling
Peter Reinhardt et al.
PLOS ONE (2013)
Neuroprotective Effects of Protocatechuic Aldehyde against Neurotoxin-Induced Cellular and Animal Models of Parkinson's Disease
Xin Zhao et al.
PLOS ONE (2013)
Generation of Genetically-Modified Human Differentiated Cells for Toxicological Tests and the Study of Neurodegenerative Diseases
Stefan Schildknecht et al.
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2013)
Using Human Pluripotent Stem Cell-Derived Dopaminergic Neurons to Evaluate Candidate Parkinson's Disease Therapeutic Agents in MPP+ and Rotenone Models
Jun Peng et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease
Lars Toenges et al.
BRAIN (2012)
Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease
Adriana Sanchez-Danes et al.
EMBO MOLECULAR MEDICINE (2012)
Industrial toxicants and Parkinson's disease
W. Michael Caudle et al.
NEUROTOXICOLOGY (2012)
Uncoupling of ATP-depletion and cell death in human dopaminergic neurons
Dominik Poeltl et al.
NEUROTOXICOLOGY (2012)
Characterization of Mouse Cell Line IMA 2.1 as a Potential Model System to Study Astrocyte Functions
Stefan Schildknecht et al.
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2012)
Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice
Francisco Pan-Montojo et al.
SCIENTIFIC REPORTS (2012)
Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing
B. Zimmer et al.
CELL DEATH AND DIFFERENTIATION (2011)
Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection
Zsigmond Tamas Kincses et al.
CNS NEUROSCIENCE & THERAPEUTICS (2011)
Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line
Diana Scholz et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Priorities in Parkinson's disease research
Wassilios G. Meissner et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying Agents
Moussa B. H. Youdim
Experimental Neurobiology (2011)
Astrocytes: biology and pathology
Michael V. Sofroniew et al.
ACTA NEUROPATHOLOGICA (2010)
Ex vivo supplementation with nicotinic acid enhances cellular poly(ADP-ribosyl)ation and improves cell viability in human peripheral blood mononuclear cells
Kathrin Weidele et al.
BIOCHEMICAL PHARMACOLOGY (2010)
A Simple Method for Large-Scale Generation of Dopamine Neurons From Human Embryonic Stem Cells
Asuka Morizane et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2010)
Modeling Parkinson's Disease
C. Warren Olanow et al.
ANNALS OF NEUROLOGY (2009)
Targets for neuroprotection in Parkinson's disease
Talene A. Yacoubian et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Can cellular models revolutionize drug discovery in Parkinson's disease?
Birgitt Schuele et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Generation of dopaminergic neurons from human fetal mesencephalic progenitors after co-culture with striatal-conditioned media and exposure to lowered oxygen
Shuang Liu et al.
BRAIN RESEARCH BULLETIN (2009)
NEUROSCIENCE Glia - more than just brain glue
Nicola J. Allen et al.
NATURE (2009)
Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells
Stefan Schildknecht et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
In vitro neuronal and glial differentiation from embryonic or adult neural precursor cells are differently affected by chronic or acute activation of microglia
Emanuele Cacci et al.
GLIA (2008)
Glial reactions in Parkinson's disease
Patrick L. McGeer et al.
MOVEMENT DISORDERS (2008)
Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease
Ira Shoulson et al.
NEUROLOGY (2007)
An in vitro model of human dopaminergic neurons derived from embryonic stem cells:: MPP+ toxicity and GDNF neuroprotection
Xianmin Zeng et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway
J Lotharius et al.
JOURNAL OF NEUROSCIENCE (2005)
Derivation of midbrain dopamine neurons from human embryonic stem cells
AL Perrier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347
J Falsig et al.
JOURNAL OF IMMUNOLOGY (2004)
Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture
TC Schulz et al.
STEM CELLS (2004)
Strain-dependent susceptibility to MPTP and MPP+-induced parkinsonism is determined by glia
M Smeyne et al.
GLIA (2001)
Astrocytes contribute to neuronal impairment in βA toxicity increasing apoptosis in rat hippocampal neurons
F Malchiodi-Albedi et al.
GLIA (2001)
Microglial secreted cathepsin B induces neuronal apoptosis
PJ Kingham et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Phagocytosis of nonapoptotic cells dying by caspase-independent mechanisms
UA Hirt et al.
JOURNAL OF IMMUNOLOGY (2000)